Frontotemporal dementia (FTD) is a heterogeneous clinical syndrome associated with
frontotemporal lobar degeneration (FTLD) as a relatively consistent neuropathological …

Frontotemporal dementia (FTD) is a clinical syndrome with a heterogeneous molecular
basis. The past decade has seen the discovery of several new FTD‐causing genetic …

Frontotemporal lobar degeneration (FTLD) is the umbrella term encompassing a
heterogeneous group of pathological disorders. With recent discoveries, the FTLDs have …

Frontotemporal lobar degeneration (FTLD) comprises two main classes of
neurodegenerative diseases characterized by neuronal/glial proteinaceous inclusions (ie …

Work done over the past decade has led to a molecular understanding of frontotemporal
lobar degeneration (FTLD), a deadly disease that afflicts patients in mid‐life. It is a common …

One year ago, in this journal, we published a recommended nomenclature for the
neuropathologic subtypes of frontotemporal lobar degeneration (FTLD)[7]. A major impetus …

Frontotemporal lobar degeneration (FTLD) describes a spectrum of clinically, pathologically
and genetically heterogeneous neurodegenerative disorders of unknown aetiology. FTLD …

Frontotemporal lobar degeneration (FTLD) is one of the most common causes of early-onset
dementia and presents with early social–emotional–behavioural and/or language changes …

Frontotemporal lobar degeneration (FTLD) is clinically, pathologically and genetically
heterogeneous. Three major proteins are implicated in its pathogenesis. About half of cases …

Frontotemporal lobar degeneration (FTLD) encompasses a group of diseases characterized
by neuronal loss and gliosis of the frontal and temporal lobes. Almost all cases of FTLD can …